L'Oreal to buy 10% stake in Swiss skincare firm GaldermaL'Oreal will acquire a 10% stake in Swiss skin care firm Galderma from a group of major shareholders, the two companies said on Monday, as ...
European stocks hit near six-month low on US recession fearsEuropean equities hit a six-month low on Monday amid global market concerns over a potential U.S. economic downturn. The STOXX 600 index de...
Global IPO revival lags first quarter share sales as markets rallyDealmaking in global equity capital markets had its strongest start in three years in 2024 as economic uncertainty waned and stocks rallied...
ADIA, HarbourVest eye minor stake in CohanceADIA and HarbourVest are in discussions to acquire a minority stake in Cohance Lifesciences, a pharmaceuticals platform owned by Advent Int...
Sun Pharma's US subsidiary acquires Galderma's companies in US, Japan & CanadaTaro has paid around $99.3 million after taking into account working capital adjustments.
Stocks in the news: TCS, Adani Ports, NMDC, Dish TV, IOC and Sun PharmaThe Rs 18,000 crore share buyback of TCS will kick off today and the company will continue to accept shares till March 23. It plans to buy ...
Alembic Pharma's JV gets USFDA nod for skin disorder treatment drugDesonide lotion is low to medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of cortic...
Alembic Pharma gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals on Friday said its joint venture has received nod from the US health regulator for generic Adapalene gel used for t...
Alembic Pharma JV gets USFDA nod for plaque psoriasis treatment drugAlembic has a cumulative total of 103 ANDA approvals (91 final approvals and 12 tentative approvals) from USFDA.
Glenmark gets USFDA nod for psoriasis sprayGlenmark Pharmaceuticals Inc, USA has received final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propio...
Nestle looks to diversify into premium coffee, cerealsIt is also planning consolidating its offerings and adding new categories so as continue with double digit growth.
Nestle India to change tack to value growth: CEONestle India is now looking ahead with renewed vigour and focus on nutrition while expanding in other categories in oder to be counted amon...
Sun Pharmaceuticals among bidders for Bayer’s dermatology brandsPrivate equity players KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may also be looking at buying the same assets.
Galderma eyes skin boosters to capture Indian beauty marketGalderma, owned by Nestle, is betting on anti-ageing injectables range and expects to capture a substantial share in India's booming beauty...
L'oreal to buy back shares from Nestle for $8.2 billionL'Oréal, world’s largest maker of cosmetics, will pay about $8.2 billion to buy back 8% of its shares from Nestlé, the companies said in a ...
Skin care firm Galderma eyes Rs 500 cr sales in India by 2018Swiss-based Galderma, a joint venture between Nestlé and L'Oréal, today said it is aiming at around five-fold growth in sales to Rs 500 cro...
Lupin gets US nod for Armodafinil tablets, Doxycycline capsulesDrug firm Lupin today said the company's US subsidiary has received tentative approvals for its Armodafinil tablets and Doxycycline capsule...